Dr Jennifer Lees

Senior Clinical Research Fellow/ Honorary Consultant (Cardiovascular & Metabolic Health)

telephone: 0141 330 8015
email: Jennifer.Lees@glasgow.ac.uk

BHF Glasgow Cardiovascular Research Centre, 126 University Avenue, Glasgow, G12 8TA

Biography

Dr Jennifer Lees, MA (Cantab) MBChB MRCP(Neph) PhD FERA, is a Wellcome Trust Early Career Fellow and Lead for Data Science (School of Cardiovascular and Metabolic Health, University of Glasgow) and Honorary Consultant Nephrologist (NHS Greater Glasgow and Clyde). She graduated from the Universities of Cambridge and Edinburgh then moved to Glasgow to train in Renal and General Internal Medicine in 2013.

Dr Lees undertook a PhD at the University of Glasgow exploring the role of vitamin K supplementation in vascular health and disease among patients with kidney disease. She led the ViKTORIES trial (ISRCTN22012044; Kidney Research UK) and was a co-investigator on the K4Kidneys trial (ISRCTN21444964; British Heart Foundation). During a post-doctoral lectureship (Chief Scientist Office, Scotland), Dr Lees explored the relationship between chronic kidney disease using healthcare data. Using routine healthcare and trial individual participant-level data, Dr Lees is now investigating the role of kidney function in the selection, delivery, efficacy and safety of cancer treatments, and the influence on subsequent outcomes (Wellcome Trust, 2024-2029).

In 2022, Dr Lees won two prestigious awards for significant contributions to renal research as a junior investigator: the UK Kidney Association Raine Award and European Renal Association (ERA) Eberhard Ritz Award for Clinical Science, and was recognised as a “Rising Star” by the International Society of Nephrology. Dr Lees is an ERA Ordinary Council Member (2024-present); Visual Abstracts (2019-present) and Biomarkers/Formula Editor (2023-present) for Nephrology Dialysis Transplantation; lead for the West of Scotland Kidney Patient and Public Involvement and Engagement group; OurFutureHealth Research Scholar; an active member of the CKD Prognosis Consortium, UK Kidney Association eGFR group and UK Renal Trials Network.

Research interests

Research Theme: Cardiovascular Data Science

Dr Lees works within the Renal Research Team and is a member of the Cardio-Nephro-Oncology (CaNOn) Research Group. Dr Lees is interested in: using data science and clinical trials to understand and improve the long-term risks associated with chronic kidney disease (CKD), particularly cardiovascular disease and cancer; use of cystatin C for risk-stratification of adverse outcomes; sex disparities in the care and outcomes of people with CKD.

Research groups

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2013 | 2012 | 2011 | 2008 | 2007

Number of items: 68.

2024

Rochmawati, I. D., Deo, S. , Lees, J. S. , Mark, P. B. , Sattar, N. , Celis-Morales, C. , Pell, J. P. , Welsh, P. and Ho, F. K. (2024) Adding traditional and emerging biomarkers for risk assessment in secondary prevention: a prospective cohort study of 20,656 patients with cardiovascular disease. European Journal of Preventive Cardiology, (doi: 10.1093/eurjpc/zwae352) (PMID:39474888) (Early Online Publication)

Liu, Q., Celis-Morales, C. , Lees, J. S. , Sattar, N. , Ho, F., Pell, J. P. , Mark, P. B. and Welsh, P. (2024) Change in physical activity and its association with decline in kidney function: A UK Biobank-based cohort study. Journal of Cachexia, Sarcopenia and Muscle, 15(5), pp. 2046-2055. (doi: 10.1002/jcsm.13551) (PMID:39155482) (PMCID:PMC11446710)

Marshall, W. R., Curran, G. A., Traynor, J. P., Gillis, K. A. , Mark, P. B. and Lees, J. S. (2024) Sodium zirconium cyclosilicate treatment and rates of emergency interventions for hyperkalaemia: a propensity-score weighted case-control study. Clinical Kidney Journal, (doi: 10.1093/ckj/sfae313) (Accepted for Publication)

Elyan, B. M.P. , Sullivan, M. K. , Hedley, J., De La Mata, N., Webster, A. C., Venugopal, B., Jones, R. J. , Lang, N. N. , Mark, P. B. and Lees, J. S. (2024) The impact of VEGF signalling pathway inhibitors and/or immune checkpoint inhibitors on kidney function over time: a single centre retrospective analysis. BJC Reports, 2, 57. (doi: 10.1038/s44276-024-00081-7)

Sullivan, M. K. , Lees, J. S. , Rosales, B. M., Cutting, R., Wyld, M. L., Woodward, M., Webster, A. C., Mark, P. B. and De La Mata, N. (2024) Sex and the relationship between cardiometabolic risk factors and estimated GFR Decline: a population-based cohort study. American Journal of Kidney Diseases, (doi: 10.1053/j.ajkd.2024.05.007) (PMID:39053834) (In Press)

Lees, J. S. et al. (2024) Participant characteristics and exclusion from trials: a meta-analysis of individual participant-level data from phase 3/4 industry-funded trials in chronic medical conditions. BMJ Medicine, 3(1), e000732. (doi: 10.1136/bmjmed-2023-000732)

Mayne, K. J., Hanlon, P. and Lees, J. S. (2024) Detecting and managing the patient with chronic kidney disease in primary care: A review of the latest guidelines. Diabetes, Obesity and Metabolism, (doi: 10.1111/dom.15625) (PMID:38699995) (Early Online Publication)

Lees, J. S. , Fabian, J. and Shlipak, M. G. (2024) Cystatin C should be routinely available for estimating kidney function. Current Opinion in Nephrology and Hypertension, 33(3), pp. 337-343. (doi: 10.1097/MNH.0000000000000980) (PMID:38411195)

Rankin, S., Elyan, B. , Jones, R. , Venugopal, B., Mark, P. B. , Lees, J. S. , Petrie, M. C. and Lang, N. N. (2024) Cardiovascular eligibility criteria and adverse event reporting in combined immune checkpoint and VEGF inhibitors trials. JACC: CardioOncology, 6(2), pp. 267-279. (doi: 10.1016/j.jaccao.2023.12.010) (PMID:38774021) (PMCID:PMC11103039)

Chen, D. C. et al. (2024) Cystatin C- and creatinine-based estimated GFR differences: prevalence and predictors in the UK Biobank. Kidney Medicine, 6(4), 100796. (doi: 10.1016/j.xkme.2024.100796) (PMID:8567244) (PMCID:PMC10986041)

Shemilt, R. et al. (2024) Sex differences in cancer outcomes across the range of eGFR. Nephrology Dialysis Transplantation, (doi: 10.1093/ndt/gfae059) (PMID:38460949) (Early Online Publication)

2023

Mayne, K. J. et al. (2023) Effects of empagliflozin on fluid overload, weight and blood pressure in chronic kidney disease. Journal of the American Society of Nephrology, (doi: 10.1681/ASN.0000000000000271) (PMID:38082486) (Early Online Publication)

Jani, B. D. , Sullivan, M. K. , Hanlon, P. , Nicholl, B. I. , Lees, J. S. , Brown, L., MacDonald, S. , Mark, P. B. , Mair, F. S. and Sullivan, F. M. (2023) Personalised lung cancer risk stratification and lung cancer screening: do general practice electronic medical records have a role? British Journal of Cancer, (doi: 10.1038/s41416-023-02467-9) (PMID:37880510) (Early Online Publication)

Radley, A., Lees, J. S. and Stevens, K. I. (2023) Cardiovascular disease in older women with CKD. Clinical Kidney Journal, 16(12), pp. 2304-2308. (doi: 10.1093/ckj/sfad235) (PMID:38046012) (PMCID:PMC10689181)

Lees, J. S. and Mark, P. B. (2023) GFR slope as a surrogate marker for future kidney failure. Nature Reviews Nephrology, 19, pp. 625-626. (doi: 10.1038/s41581-023-00748-3) (PMID:37495682)

Lees, J. S. , De La Mata, N. L., Sullivan, M. K. , Wyld, M. L., Rosales, B. M., Cutting, R., Hedley, J. A., Rutherford, E., Mark, P. B. and Webster, A. C. (2023) Sex differences in associations between creatinine and cystatin C-based kidney function measures with stroke and major bleeding. European Stroke Journal, 8(3), pp. 756-768. (doi: 10.1177/23969873231173282)

Shemilt, R. et al. (2023) Sex differences in the diagnosis of advanced cancer and subsequent outcome in people with chronic kidney disease: an analysis of a national population cohort. medRxiv, (doi: 10.1101/2023.08.22.23294412)

Stevens, K. I. and Lees, J. S. (2023) Measure and risk: cystatin C, creatinine and controversy in CKD. Nephrology Dialysis Transplantation, 38(8), pp. 1785-1788. (doi: 10.1093/ndt/gfad113) (PMID:37245066)

Elyan, B. M.P. , Rankin, S., Jones, R., Lang, N. N. , Mark, P. B. and Lees, J. S. (2023) Kidney disease patient representation in trials of combination therapy with VEGF-signaling pathway inhibitors and immune checkpoint inhibitors: a systematic review. Kidney Medicine, 5(7), 100672. (doi: 10.1016/j.xkme.2023.100672) (PMID:37492115) (PMCID:PMC10363559)

Grant, C. H. , Salim, E., Lees, J. S. and Stevens, K. I. (2023) Deprivation and chronic kidney disease—a review of the evidence. Clinical Kidney Journal, 16(7), pp. 1081-1091. (doi: 10.1093/ckj/sfad028) (PMID:37398697) (PMCID:PMC10310512)

Lees, J. S. , Dobbin, S. J.H. , Elyan, B. M.P. , Gilmour, D. F., Tomlinson, L. P., Lang, N. N. and Mark, P. B. (2023) A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes. Nephrology Dialysis Transplantation, 38(7), pp. 1666-1681. (doi: 10.1093/ndt/gfac305) (PMID:36318455) (PMCID:PMC10310520)

Mayne, K. J., Sullivan, M. K. and Lees, J. S. (2023) Sex and gender differences in the management of chronic kidney disease and hypertension. Journal of Human Hypertension, (doi: 10.1038/s41371-023-00843-9) (Early Online Publication)

Stevens, K. I., Graham-Brown, M. and Lees, J. S. (2023) Let's get physical: considering and overcoming the barriers to physical activity in CKD. Nephrology Dialysis Transplantation, 38(6), pp. 1405-1407. (doi: 10.1093/ndt/gfad002) (PMID:36662119)

Lees, J. S. , Elyan, B. M.P., Hermann, S. M., Lang, N. N. , Jones, R. J. and Mark, P. B. (2023) The ‘other’ big complication: how chronic kidney disease impacts on cancer risks and outcomes. Nephrology Dialysis Transplantation, 38(5), pp. 1071-1079. (doi: 10.1093/ndt/gfac011) (PMID:35090037) (PMCID:PMC10157781)

Mayne, K. J., Lees, J. S. and Herrington, W. G. (2023) Bioimpedance in CKD: an untapped resource? Nephrology Dialysis Transplantation, 38(3), pp. 583-585. (doi: 10.1093/ndt/gfac275) (PMID:36260361) (PMCID:PMC9976732)

Mayne, K. J., Lees, J. S. and Mark, P. B. (2023) Cardiovascular complications of chronic kidney disease. Medicine, 51(3), pp. 190-195. (doi: 10.1016/j.mpmed.2022.12.008)

Mayne, K. J., Lees, J. S. , Rutherford, E., Thomson, P. C., Traynor, J. P., Dey, V. , Lang, N. N. and Mark, P. B. (2023) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort. Clinical Kidney Journal, 16(3), pp. 512-520. (doi: 10.1093/ckj/sfac248) (PMID:36865003) (PMCID:PMC9972818)

Chen, D. C., Lees, J. S. , Lu, K., Scherzer, R., Rutherford, E., Mark, P. B. , Kanaya, A. M., Shlipak, M. G. and Estrella, M. M. (2023) Differential associations of cystatin C versus creatinine‐based kidney function with risks of cardiovascular event and mortality among South Asian individuals in the UK Biobank. Journal of the American Heart Association, 12(3), e027079. (doi: 10.1161/JAHA.122.027079) (PMID:36695320) (PMCID:PMC9973614)

Sullivan, M. K. et al. (2023) Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study. British Journal of General Practice, 73(727), e141-e147. (doi: 10.3399/BJGP.2022.0145) (PMID:36376072) (PMCID:PMC9678375)

2022

Lithgow, H. et al. (2022) Protocol for a randomised controlled trial to investigate the effects of vitamin K2 on recovery from muscle-damaging resistance exercise in young and older adults—the TAKEOVER study. Trials, 23, 1026. (doi: 10.1186/s13063-022-06937-y) (PMID:36539791) (PMCID:PMC9764575)

Lees, J. S. and Shlipak, M. G. (2022) Age-adapted eGFR thresholds underestimate the risks beyond kidney failure associated with CKD in older populations. Journal of the American Geriatrics Society, 70(12), pp. 3660-3664. (doi: 10.1111/jgs.18046) (PMID:36151987)

Mayne, K. J., Shemilt, R., Keane, D. F., Lees, J. S. , Mark, P. B. and Herrington, W. G. (2022) Bioimpedance indices of fluid overload and cardiorenal outcomes in heart failure and chronic kidney disease: a systematic review. Journal of Cardiac Failure, 28(11), pp. 1628-1641. (doi: 10.1016/j.cardfail.2022.08.005) (PMID:36038013)

Lees, J. S. , Rutherford, E., Stevens, K. I., Chen, D. C., Scherzer, R., Estrella, M. M., Sullivan, M. K. , Ebert, N., Mark, P. B. and Shlipak, M. G. (2022) Assessment of Cystatin C level for risk stratification in adults with chronic kidney disease. JAMA Network Open, 5(10), e2238300. (doi: 10.1001/jamanetworkopen.2022.38300) (PMID:36282503) (PMCID:PMC9597396)

Lithgow, H. et al. (2022) Protocol for a randomised controlled trial to investigate the effects of vitamin K2 on recovery from muscle damaging resistance exercise in young and older adults – The TAKEOVER study. Research Square, (doi: 10.21203/rs.3.rs-1020009/v1)

Lees, J. , Rutherford, E., Stevens, K., Chen, D., Scherzer, R., Estrella, M., Sullivan, M. , Ebert, N., Mark, P. and Shlipak, M. (2022) FC077: Cystatin C testing improves risk stratification associated with chronic kidney disease without adopting age-adapted diagnostic thresholds : a UK Biobank Study. Nephrology Dialysis Transplantation, 37(Sup 3), I842-I843. (doi: 10.1093/ndt/gfac114.001)

Lees, J. S. and Mark, P. B. (2022) Insights into vitamin K metabolism in chronic kidney disease: more complicated than kale deficiency. Kidney International, 101(2), pp. 216-219. (doi: 10.1016/j.kint.2021.11.022) (PMID:35065688)

Sullivan, M. K. et al. (2022) Acute kidney injury in patients hospitalised with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study. Nephrology Dialysis Transplantation, 37(2), pp. 271-284. (doi: 10.1093/ndt/gfab303) (PMID:34661677) (PMCID:PMC8788218)

Lees, J. S. and Mark, P. B. (2022) Vitamin K supplementation and vascular health after kidney transplantation: authors' response. American Journal of Transplantation, 22(1), pp. 320-321. (doi: 10.1111/ajt.16769) (PMID:34291553)

Lees, J. S. et al. (2022) Effect of age, sex, and morbidity count on trial attrition: meta-analysis of individual participant level data from phase 3/4 industry funded clinical trials. BMJ Medicine, 1(1), e000217. (doi: 10.1136/bmjmed-2022-000217) (PMID:36936559) (PMCID:PMC9978693)

2021

Rankin, A. J. et al. (2021) Myocardial changes on 3T cardiovascular magnetic resonance imaging in response to haemodialysis with fluid removal. Journal of Cardiovascular Magnetic Resonance, 23, 125. (doi: 10.1186/s12968-021-00822-4) (PMCID:PMC8580743)

Sullivan, M. K. et al. (2021) Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort. Clinical Kidney Journal, 14(11), pp. 2409-2419. (doi: 10.1093/ckj/sfab079) (PMCID:PMC8573008)

Lees, J. S. et al. (2021) The ViKTORIES trial: a randomised, double-blind, placebo-controlled trial of vitamin K supplementation to improve vascular health in kidney transplant recipients. American Journal of Transplantation, 21(10), pp. 3356-3368. (doi: 10.1111/ajt.16566) (PMID:33742520)

Rankin, A. J. et al. (2021) Global longitudinal strain by feature tracking cardiovascular MRI predicts mortality in patients with end stage kidney disease. Clinical Kidney Journal, 14(10), pp. 2187-2196. (doi: 10.1093/ckj/sfab020)

Lees, J. S. et al. (2021) Kidney function and cancer risk: an analysis using creatinine and cystatin C in a cohort study. EClinicalMedicine, 38, 101030. (doi: 10.1016/j.eclinm.2021.101030) (PMID:34505030)

Lees, J. S. , Mark, P. B. and Witham, M. D. (2021) Vitamin K and vascular calcification. Current Opinion in Nephrology and Hypertension, 30(4), pp. 430-436. (doi: 10.1097/MNH.0000000000000712) (PMID:33871429)

Li, K. K. et al. (2021) Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface. Journal of Infection, 83(1), pp. 96-103. (doi: 10.1016/j.jinf.2021.04.020) (PMID:33895226) (PMCID:PMC8061788)

Edy, E. et al. (2021) Cardiovascular magnetic resonance for the detection of descending thoracic aorta calcification in patients with end-stage renal disease. Journal of Cardiovascular Magnetic Resonance, 23(1), 85. (doi: 10.1186/s12968-021-00769-6) (PMID:34162405) (PMCID:PMC8223384)

Lees, J. S. and Mark, P. B. (2021) Fruit for thought: lifestyle interventions to reduce the risk of future chronic kidney disease. Nephrology Dialysis Transplantation, 36(6), pp. 963-965. (doi: 10.1093/ndt/gfaa266) (PMID:33313844)

O’Sullivan, E. D., Lees, J. S. , Howie, K. L., Pugh, D., Gillis, K. A. , Traynor, J. P., Macintyre, I. and Mark, P. B. (2021) Prolonged SARS-CoV-2 viral shedding in patients with chronic kidney disease. Nephrology, 26(4), pp. 328-332. (doi: 10.1111/nep.13844) (PMID:33368892)

Lees, J. S. and Mark, P. B. (2021) Cystatin C to predict renal disease and cardiovascular risk. Nephrology Dialysis Transplantation, 36(1), pp. 39-41. (doi: 10.1093/ndt/gfaa152) (PMID:32514520)

2020

Witham, M. D. et al. (2020) Vitamin K supplementation to improve vascular stiffness in chronic kidney disease: the K4Kidneys randomised controlled trial. Journal of the American Society of Nephrology, 31(10), pp. 2434-2445. (doi: 10.1681/ASN.2020020225) (PMID:32817311)

Lees, J. S. , Mangion, K., Rutherford, E., Witham, M. D., Woodward, R., Roditi, G., Hopkins, T., Brooksbank, K., Jardine, A. and Mark, P. B. (2020) Vitamin K for kidney transplant organ recipients: investigating vEssel stiffness (ViKTORIES): study rationale and protocol of a randomised controlled trial. Open Heart, 7, e001070. (doi: 10.1136/openhrt-2019-001070) (PMID:32675297) (PMCID:PMC7368482)

2019

Grant, C. H. , Gillis, K. A. , Lees, J. S. , Traynor, J. P., Mark, P. B. and Stevens, K. I. (2019) Proton pump inhibitor use and progression to major adverse renal events: a competing risk analysis. QJM: An International Journal of Medicine, 112(11), pp. 835-840. (doi: 10.1093/qjmed/hcz166) (PMID:31251364)

Lees, J. S. et al. (2019) Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease. Nature Medicine, 25, pp. 1753-1760. (doi: 10.1038/s41591-019-0627-8) (PMID:31700174) (PMCID:PMC6858876)

Elyan, B. M.P., Lees, J. S. , Gillis, K. A. , Mackinnon, B., Fox, J. G., Geddes, C. C. and McQuarrie, E. P. (2019) Obesity is not associated with progression to end stage renal disease in patients with biopsy-proven glomerular diseases. BMC Nephrology, 20, 237. (doi: 10.1186/s12882-019-1434-7) (PMID:31266462) (PMCID:PMC6604373)

Lees, J.S. , Chapman, F.A., Witham, M.D., Jardine, A.G. and Mark, P.B. (2019) Vitamin K status, supplementation and vascular disease: a systematic review and meta-analysis. Heart, 105(12), pp. 938-945. (doi: 10.1136/heartjnl-2018-313955) (PMID:30514729)

Gillis, K. A. , Lees, J. S. , Ralston, M. R., Glen, J. A., Stevenson, K. S., McManus, S. K., Geddes, C. C., Clancy, M., Traynor, J. P. and Mark, P. B. (2019) Interaction between socioeconomic deprivation and likelihood of pre‐emptive transplantation: influence of competing risks and referral characteristics – a retrospective study. Transplant International, 32(2), pp. 153-162. (doi: 10.1111/tri.13336) (PMID:30152890)

Lees, J.S. , Findlay, M.D., Mark, P.B. and Geddes, C.C. (2019) The impact of coronary angiography on renal transplant function. QJM: An International Journal of Medicine, 112(1), pp. 23-27. (doi: 10.1093/qjmed/hcy216) (PMID:30295913)

2018

Lees, J. S. , McQuarrie, E. P. and Mackinnon, B. (2018) Renal biopsy: it is time for pragmatism and consensus. Clinical Kidney Journal, 11(5), pp. 605-609. (doi: 10.1093/ckj/sfy075) (PMID:30289128) (PMCID:PMC6165764)

Stoumpos, S., Lees, J. , Welsh, P. , Hund, M., Geddes, C. C., Nelson, S. M. and Mark, P. B. (2018) The utility of anti-Müllerian hormone in women with chronic kidney disease, on haemodialysis and after kidney transplantation. Reproductive BioMedicine Online, 36(2), pp. 219-226. (doi: 10.1016/j.rbmo.2017.11.003) (PMID:29233504)

2017

Lees, J. S. , McQuarrie, E. P., Mordi, N., Geddes, C. C., Fox, J. G. and Mackinnon, B. (2017) Risk factors for bleeding complications after nephrologist-performed native renal biopsy. Clinical Kidney Journal, 10(4), pp. 573-577. (doi: 10.1093/ckj/sfx012) (PMID:28852497) (PMCID:PMC5570080)

2015

Lees, J. S. , Mark, P. B. and Jardine, A. G. (2015) Cardiovascular complications of chronic kidney disease. Medicine, 43(8), pp. 469-473. (doi: 10.1016/j.mpmed.2015.05.009)

2013

Altman, D. G., Antonic, A., Sena, E. S., Lees, J. S. , Wills, T. E., Skeers, P., Batchelor, P. E., Macleod, M. R. and Howells, D. W. (2013) Stem cell transplantation in traumatic spinal cord injury: a systematic review and meta-analysis of animal studies. PLoS Biology, 11(12), e1001738. (doi: 10.1371/journal.pbio.1001738) (PMID:24358022) (PMCID:PMC3866091)

Lees, J.S. , Church, N., Langdale-Brown, B., Bellamy, C., Gibson, P. and Watson, S. (2013) IgG4-related disease: a novel, important but easily missed condition. Journal of the Royal College of Physicians of Edinburgh, 43(2), pp. 126-133. (doi: 10.4997/JRCPE.2013.208) (PMID:23734354)

2012

Lees, J. S. , Sena, E. S., Egan, K. J., Antonic, A., Koblar, S. A., Howells, D. W. and Macleod, M. R. (2012) Stem cell‐based therapy for experimental stroke: a systematic review and meta‐analysis. International Journal of Stroke, 7(7), pp. 582-588. (doi: 10.1111/j.1747-4949.2012.00797.x) (PMID:22687044)

2011

Lees, J.S. , Mishra, N.K., Saini, M., Lyden, P.D. and Shuaib, A. (2011) Low body temperature does not compromise the treatment effect of alteplase. Stroke, 42(9), pp. 2618-2621. (doi: 10.1161/STROKEAHA.110.611210)

2008

Quinn, T.J. , Dawson, J. , Lees, J.S. , Chang, T.P., Walters, M.R. and Lees, K.R. (2008) Time spent at home poststroke: “home-time” a meaningful and robust outcome measure for stroke trials. Stroke, 39(1), pp. 231-233. (doi: 10.1161/STROKEAHA.107.493320)

2007

Dawson, J. , Lees, J.S. , Chang, T.P., Walters, M.R. , Ali, M. , Davis, S.M., Diener, H.C. and Lees, K.R. (2007) Association between disability measures and healthcare costs after initial treatment for acute stroke. Stroke, 38(6), pp. 1893-1898. (doi: 10.1161/STROKEAHA.106.472381)

This list was generated on Sat Nov 23 21:17:45 2024 GMT.

Jump to: Articles

Number of items: 68.

Articles

Shemilt, R. et al. (2024) Sex differences in cancer outcomes across the range of eGFR. Nephrology Dialysis Transplantation, (doi: 10.1093/ndt/gfae059) (PMID:38460949) (Early Online Publication)

Lees, J. S. and Mark, P. B. (2023) GFR slope as a surrogate marker for future kidney failure. Nature Reviews Nephrology, 19, pp. 625-626. (doi: 10.1038/s41581-023-00748-3) (PMID:37495682)

Mayne, K. J., Lees, J. S. and Mark, P. B. (2023) Cardiovascular complications of chronic kidney disease. Medicine, 51(3), pp. 190-195. (doi: 10.1016/j.mpmed.2022.12.008)

Lees, J. S. and Mark, P. B. (2021) Cystatin C to predict renal disease and cardiovascular risk. Nephrology Dialysis Transplantation, 36(1), pp. 39-41. (doi: 10.1093/ndt/gfaa152) (PMID:32514520)

Lees, J. S. , Mark, P. B. and Jardine, A. G. (2015) Cardiovascular complications of chronic kidney disease. Medicine, 43(8), pp. 469-473. (doi: 10.1016/j.mpmed.2015.05.009)

This list was generated on Sat Nov 23 21:17:45 2024 GMT.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

Kidney function as a modulator of cancer treatment: a comprehensive analysis from population data, health records, national registries and individual participant-level trial data.
Wellcome Trust
2024 - 2029
Defining the bi-directional relationship between cancer and kidney disease
Office of the Chief Scientific Adviser
2020 - 2022
Vitamin K in Transplanted Kidney Organ Recipients: Investigating vEssel Stiffness (ViKTORIES)
Kidney Research UK
2017 - 2019

Supervision

Elyan, Benjamin
How does cancer interact with kidney health and disease?
Mayne, Kaitlin
Effects of empagliflozin on fluid overload, weight and blood pressure in chronic kidney disease
McChrystal, Ryan
Predictors of early trial termination using individual-level participant data and aggregate-level data from multiple trials

Teaching

Dr Lees contributes to teaching delivery and assessment of undergraduate courses within the College of Medical, Veterinary & Life Sciences, and supervises BSc, MSc and PhD research projects.

Case Based Learning - Nephrology & Urology, Medicine MBChB
Cardiovascular Studies Specialist Course, BSc (Med Sci) Clinical Medicine
Human Biology & Physiology 3A BIOL4228

Professional activities & recognition

Prizes, awards & distinctions

2022: Raine Award (UK Kidney Association)
2022: Eberhard Ritz Award for Clinical Science (European Renal Association)
2024: Fellow of the European Renal Association (European Renal Association)

Research fellowships

2017 - 2019: Kidney Research UK
2020 - 2022: Chief Scientist Office
2024 - 2029: Wellcome Trust Early Career Award

Editorial boards

2019 - Present: Nephrology Dialysis Transplantation

Professional & learned societies

2024 - Present: Council Member, European Renal Association
2018 - Present: Electronic Communications Committee, European Renal Association
2019 - 2023: Social Media Team, European Renal Association

Selected international presentations

2024: International Society of Nephrology PARADIGM Consensus Meeting (Vancouver)
2024: European Renal Association Annual Congress (Stockholm)
2023: World Congress of Nephrology (Bangkok)
2023: European Society of Hypertension (Milan/Hybrid)
2023: Pre-hypertension, Hypertension and Cardiometabolic Syndrome meeting (Prague/Hybrid)
2022: European Renal Association Annual Congress (Paris)
2021: European Renal Association Annual Congress (Virtual)

250px

We use cookies

Necessary cookies

Analytics cookies

Clarity